article thumbnail

Where telemedicine is headed now that the PHE has ended

Healthcare IT News - Telehealth

Further, what should CIOs and other health IT leaders at hospitals and health systems be doing to address new telemedicine challenges? What does the end of the PHE mean for the future of telemedicine? For example, Medicare reimbursement of telemedicine will continue by and large as it did during COVID until the end of 2024.

article thumbnail

AccessHealth uses telemedicine to boost mental health visits by 10% during COVID-19

Healthcare IT News - Telehealth

COVID-19 spurred Houston-based AccessHealth to quickly scale up its telemedicine offerings, just as it did with most other health systems nationwide. " Finally, prior to CMS loosening telemedicine policy for the pandemic, reimbursement was a concern. NextGen and Zoom for Healthcare both were proposed as telemedicine vendors.

COVID-19 175
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

December 2023 Regulatory Compliance Updates

Verisys

US S3193 DEA: The DEA and Department of Health and Human Services (HHS) has announced the extension of current telemedicine flexibilities through December 31, 2024. In particular, practitioners are allowed to prescribe controlled medications via telemedicine, even when the practitioner has not conducted an in-person evaluation.

article thumbnail

We Look Forward to Seeing You at the Foley & Lardner Digital Health Legal Session and Reception in Tel Aviv

Healthcare Law Today

Telehealth : (a) Summarize the current regulatory landscape as it relates to telemedicine; (b) Identify key considerations when using telemedicine, including licensure, medical practice standards, prescribing and reimbursement; and (c) What to expect in 2023. FDA Regulatory Considerations for the U.S.

article thumbnail

Ophelia Raises $50M to Expand Its Novel Approach to Opioid Addiction Treatment

HIT Consultant

In order to prescribe buprenorphine, clinicians need a separate license from the federal government called an x-waiver, which only 5 percent have. At its core is buprenorphine (Suboxone), a medication used to treat withdrawal and cravings while also mitigating overdose risk. A major barrier to expanding access to MAT in the U.S.

article thumbnail

Digital Health at CES 2024

Healthcare IT Today

They are still waiting on FDA clearance (like most in this space), but the concept is so simple and beautiful. Of course, these companies can’t say this is what they’re able to do until they get FDA clearance, but the early results seem promising. Here’s a look at how their demo worked for me.

FDA 116
article thumbnail

Key Legal Considerations Relating to Ketamine Behavioral Health Platforms

Health Care Law Brief

Treatment models range from more traditional psychotherapy and infusion services similar to those offered by Columbia University [2] to telemedicine-enabled psychotherapy coupled with mail-delivered tablets of ketamine under the Mindbloom model. [3] Ketamine is a Schedule III controlled substance. [4] 1] [link]. [2] 2] [link]. [3]